Transforming Cancer Clinical Research

Massive Bio


Dr. Selin Kurnaz is on a mission to transform clinical research and ultimately improve healthcare outcomes. Blessed with brains, talent and drive, she earned a PhD from University of Michigan. Thereafter, she spent years in the buttoned-down world of big consulting-driven financial deal making. Possessing exceptional confidence and perhaps more drive than many, Kurnaz was on track to launch her own private equity firm. In 2014 everything changed. Her uncle fell terribly ill—facing a life and death situation caused by cancer. Kurnaz and her tight-knit family faced a petrifying reality. It was at this point, just over four years ago, that Selin Kurnaz pivoted away from the corporate finance world of money-making as a focus to launch Massive Bio—driven by a sense of mission, purpose and all-pervasive empathy for cancer patients. Her life changed forever—she founded Massive Bio to help patients struggling with complex cancers find the help they needed. Moving forward, she would dedicate her time to building a company that delivers patients assistance with cancer genomics, test selection and treatment options where standard approaches such as chemotherapy have failed.

Read the full press release

Media Coverage


  • How Cancer Can Become Burden for An Entire Family ,

    […] is 39.7% for men and 37.6% for women.   When someone close to you gets diagnosed with cancer, it is not easy, but being there for them is important in their cancer journey.  When you are […]

  • Leave a Comment

    Your email address will not be published. Required fields are marked *

    Previous reading
    CEO talks at J.P. Morgan Healthcare Conference 2019
    Next reading
    SYNERGY-AI: Session Information